ARCHIVES

In Brief: $100 Million Being Spent On Interferon In U.S., Rauscher Says; DeVita; Criticism Deserved

This article is from The Cancer Letter archive.

Vol. 06 No. 14 | April 4, 1980

Download PDF Visit The Full Archive

Related Articles

Bepler To Lead Karmanos Cancer Institute

January 29, 2010

Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2

April 17, 1987

DeVita Says Payline Compression Leading to More Decisions By Staff On Funding

June 28, 1985

In Brief: MSKCC Launches Molecular Oncology, Genomic Center

May 23, 2014

In Brief: appropriations Approved; Grants, contracts May Flow Unimpeded; NCI Positions An Issue

December 16, 1977

Fitness Reduces Risk of Death From Lung, Colorectal, Prostate Cancer in Middle-Aged Men

May 31, 2013